(2023). Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study. 2023.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study. 2023.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.